ENGN

Latest SEC Filings & News for ENGN

2 most recent filings and news items mentioning ENGN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ENGN/news?limit=20"

Pull ENGN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
NewsJun 16, 2026Neutral

W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

View filing at SEC.gov →
RegulatoryJun 15, 2026Positive

enGene reports Q2 2026 results, plans BLA filing for detalimogene in 2H 2026

enGene announced 54% complete response rate in LEGEND pivotal cohort and plans to initiate a Biologics License Application for detalimogene in the second half of 2026 pending FDA engagement. The company reduced workforce by 50% to preserve $285 million in cash and focus on regula

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.